Tiago Silva Martins

Tiago Silva Martins

Auto-generated profile, based on publicly available information

Tiago Silva Martins

Faculty of Medicine University of Porto, Department of Community Medicine, Information and Health Decision Sciences, Porto, Portugal; CINTESIS @ RISE - Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
PAPedro Amorim
Pedro Amorim
TMTiago Silva Martins
Tiago Silva Martins
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
Pedro PereiraPedro Pereira
Pedro Pereira
Background: American Academy of Sleep Medicine guidelines suggest that clinical prediction algorithms can be used to screen patients with obstructive sleep apnea (OSA) without replacing polysomnography, the gold standard. Objective: We aimed to identify, gather, and analyze existing machine learning approaches that are being used for disease screening in adult patients with suspected OSA. Methods: We searched the MEDLINE, Scopus, and ISI Web of Knowledge databases to evaluate the validity of different machine learning techniques, with polysomnography as the gold standard outcome measure and used the Prediction Model Risk of Bias Assessment Tool (Kleijnen Systematic Reviews Ltd) to assess risk of bias and applicability of each included study. Results: Our search retrieved 5479 articles, of which 63 (1.15%) articles were included. We found 23 studies performing diagnostic model development alone, 26 with added internal validation, and 14 applying the clinical prediction algorithm to an independent sample (although not all reporting the most common discrimination metrics, sensitivity or specificity). Logistic regression was applied in 35 studies, linear regression in 16, support vector machine in 9, neural networks in 8, decision trees in 6, and Bayesian networks in 4. Random forest, discriminant analysis, classification and regression tree, and nomogram were each performed in 2 studies, whereas Pearson correlation, adaptive neuro-fuzzy inference system, artificial immune recognition system, genetic algorithm, supersparse linear integer models, and k-nearest neighbors algorithm were each performed in 1 study. The best area under the receiver operating curve was 0.98 (0.96-0.99) for age, waist circumference, Epworth Somnolence Scale score, and oxygen saturation as predictors in a logistic regression. Conclusions: Although high values were obtained, they still lacked external validation results in large cohorts and a standard OSA criteria definition. Trial Registration: PROSPERO CRD42021221339; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221339

11 February 2025 in JMIR Cardio
Verified
Journal Article
Open access
JAJoão Miguel Alves
João Miguel Alves
DMDaniel Matos
Daniel Matos
TMTiago Martins
Tiago Martins
DCDiogo Cavaco
Diogo Cavaco
PCPedro Carmo
Pedro Carmo
PAPedro Adragão
Pedro Adragão
Background: Atrial fibrillation (AF) is a prevalent arrhythmia associated with significant morbidity and mortality. Despite advancements in ablation techniques, predicting recurrence of AF remains a challenge, necessitating reliable models to identify patients at risk of relapse. Traditional scoring systems often lack applicability in diverse clinical settings and may not incorporate the latest evidence-based factors influencing AF outcomes. This study aims to develop an explainable artificial intelligence model using Bayesian networks to predict AF relapse postablation, leveraging on easily obtainable clinical variables. Objective: This study aims to investigate the effectiveness of Bayesian networks as a predictive tool for AF relapse following a percutaneous pulmonary vein isolation (PVI) procedure. The objectives include evaluating the model’s performance using various clinical predictors, assessing its adaptability to incorporate new risk factors, and determining its potential to enhance clinical decision-making in the management of AF. Methods: This study analyzed data from 480 patients with symptomatic drug-refractory AF who underwent percutaneous PVI. To predict AF relapse following the procedure, an explainable artificial intelligence model based on Bayesian networks was developed. The model used a variable number of clinical predictors, including age, sex, smoking status, preablation AF type, left atrial volume, epicardial fat, obstructive sleep apnea, and BMI. The predictive performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC-ROC) metrics across different configurations of predictors (5, 6, and 7 variables). Validation was conducted through four distinct sampling techniques to ensure robustness and reliability of the predictions. Results: The Bayesian network model demonstrated promising predictive performance for AF relapse. Using 5 predictors (age, sex, smoking, preablation AF type, and obstructive sleep apnea), the model achieved an AUC-ROC of 0.661 (95% CI 0.603‐0.718). Incorporating additional predictors improved performance, with a 6-predictor model (adding BMI) achieving an AUC-ROC of 0.703 (95% CI 0.652‐0.753) and a 7-predictor model (adding left atrial volume and epicardial fat) achieving an AUC-ROC of 0.752 (95% CI 0.701‐0.800). These results indicate that the model can effectively estimate the risk of AF relapse using readily available clinical variables. Notably, the model maintained acceptable diagnostic accuracy even in scenarios where some predictive features were missing, highlighting its adaptability and potential use in real-world clinical settings. Conclusions: The developed Bayesian network model provides a reliable and interpretable tool for predicting AF relapse in patients undergoing percutaneous PVI. By using easily accessible clinical variables, presenting acceptable diagnostic accuracy, and showing adaptability to incorporate new medical knowledge over time, the model demonstrates a flexibility and robustness that makes it suitable for real-world clinical scenarios.

9 October 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
JAJoão Miguel Alves
João Miguel Alves
TMTiago Martins
Tiago Martins
SESusana Esteves
Susana Esteves
CDCláudia Camila Dias
Cláudia Camila Dias
PRPedro Pereira Rodrigues
Pedro Pereira Rodrigues
Temporal and dynamic Bayesian networks offer a promising approach for modeling temporal relationships within health data, allowing researchers to analyze how clinical variables evolve over time. A scoping review was conducted to map the existing literature on the application of Bayesian networks for temporal modeling in a clinical context. A comprehensive search of five electronic databases (PubMed, Web of Science, Scopus, EBSCOhost, and DBLP) was conducted to identify studies utilizing temporal or dynamic Bayesian networks to model temporal relationships within a medical or clinical setting. Our search yielded 47 studies (0.44 %) from an initial pool of 10631 publications. Prognostic applications dominated the studies (74.5 %, n = 35), while diagnostic applications comprised 25.5 % (n = 12). Publication dates ranged from 2000 to 2023, with a recent surge from 2021 onwards (n = 18). Twelve medical specialties were represented, with oncology (n = 10), intensive care (n = 9), and cardiology (n = 7) being the most frequent. Standard Dynamic Bayesian Network (DBN) models were used in 72.3 % (n = 34) of the studies, with the remaining studies employing other Bayesian network types (27.7 %, n = 13). DBNs demonstrate potential for temporal modeling of clinical variables across a wide range of medical specialties, with applications in oncology, intensive care, and cardiology. Their use has been predominantly focused on life-threatening conditions, such as cancer and organ failure. However, given their ability to model temporal events, DBNs are well-suited for managing long-term patient care, particularly in chronic diseases. Expanding their application to underrepresented fields such as pneumology, mental health, and geriatrics could further enhance their impact. A surge in publications in recent years reflects a growing interest in the clinical utility for DBNs, reinforcing their role in supporting decision-making in dynamic health contexts. PROSPERO CRD42023431306.

10 May 2022 in JMIR Preprints
Verified
Preprint
Open access
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
PAPedro Amorim
Pedro Amorim
TMTiago Silva Martins
Tiago Silva Martins
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
Pedro PereiraPedro Pereira
Pedro Pereira
BACKGROUND American Academy of Sleep Medicine guidelines suggests that clinical prediction algorithms can be used to screen obstructive sleep apnea (OSA) patients without replacing polysomnography (PSG) – the gold standard. OBJECTIVE We aimed to identify, gather, and analyze existing machine learning approaches that are being used for disease screening in adult patients suspected of OSA. METHODS We searched MEDLINE, Scopus and ISI Web of Knowledge databases for evaluating the validity of different machine learning techniques, with PSG as the gold standard outcome measures. This systematic review was registered in PROSPERO under reference CRD42021221339. RESULTS Our search retrieved 5479 articles, of which 63 articles were included. We found 23 studies performing diagnostic models’ development alone, 26 with added internal validation, and 14 applying the clinical prediction algorithm to an independent sample (although not all reporting the most common discrimination metrics - sensitivity and/or specificity). Logistic regression was applied in 35 studies, linear regression in 16, support vector machine in 9, neural networks in 8, decision trees in 6, and Bayesian networks in 4. Random forest, discriminant analysis, classification and regression tree, and nomogram were each performed in 2 studies, while Pearson correlation, adaptative neuro-fuzzy inference system, artificial immune recognition system, genetic algorithm, supersparse linear integer models, and k-nearest neighbors’ algorithm each in 1 study. The best AUC was .98 [.96-.99] for age, waist circumference, Epworth somnolence, and oxygen saturation as predictors in a logistic regression. CONCLUSIONS Although high values were obtained, they still lack external validation results in large cohorts and a standard OSA criteria definition.